Fat accumulation in the liver, common in both non-drinkers (NAFLD, now MASLD) and those who consume alcohol (AFLD), may ...

Sagimet Biosciences (NASDAQ:SGMT) traded higher on Thursday after Canaccord Genuity launched its coverage with a Buy recommendation, citing the potential of its lead asset denifanstat, targeted at a ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Metabolic dysfunction-associated steatohepatitis (MASH) represents a serious form of fatty liver disease that can lead to permanent damage while producing few noticeable symptoms.

Altimmune's pemvidutide showed strong MASH resolution and good tolerability in IMPACT, but fibrosis data fell short. See why ...

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week. The pill, called resmetirom ...

This new therapeutic for advanced-stage liver disease is significant because, until now, ... Of that population, 20% have the more advanced disease form, MASH.

Dapagliflozin helped people reduce fat levels in their liver and avoid liver scarring that comes with the condition, which doctors call metabolic dysfunction-associated steatohepatitis, or MASH ...

In his 40s, Álvarez was diagnosed with fatty liver disease. Genetics can play a role, and he later learned that his mother had the same condition. "Navigating this journey has deepened my ...